News

Twist Bioscience Reports Strong Fiscal Fourth Quarter Results

1 Mins read

Shares of Twist Bioscience surged by 25% following the company’s robust performance in the fiscal fourth quarter, surpassing analysts’ expectations. The San Francisco-based biotechnology firm also provided optimistic guidance for fiscal 2024, projecting a smaller loss and higher revenue.

Impressive Financial Outlook

Twist Bioscience anticipates a significant jump in revenue for fiscal 2024, with an estimated growth rate of 16% to 18%. The projected revenue range is set between $285 million and $290 million. While the company expects a decrease in the loss from operations before taxes, estimating a decline of 15% to 18%.

Fiscal Fourth Quarter Highlights

During the most recent quarter, Twist Bioscience reported a narrower loss compared to the same period last year. The loss stood at $46.2 million, or 81 cents per share, reduced from $51.1 million, or 91 cents per share, in the previous year. This positive outcome exceeded expectations as analysts predicted a loss of 92 cents per share.

Furthermore, the revenue for the fiscal fourth quarter amounted to $66.9 million, up from $57.3 million in the comparable quarter of the previous year. This revenue figure outperformed analyst projections of $63.4 million.

Twist Bioscience continues to exhibit strong performance and promising growth prospects, positioning itself as a leading player in the biotechnology industry.

Related posts
News

U.S. Federal Reserve revokes crypto guidance for banks

1 Mins read
25th April 2025 – (Washington) The U.S. Federal Reserve announced on 24th April that it will withdraw previous guidance requiring state member…
News

Largo Reports Q1 2025 Production and Sales Results; Provides Update on Operational Turnaround Plans By Investing.com

7 Mins read
All dollar amounts expressed are in thousands of U.S. dollars unless otherwise indicated. Q1 2025 HighlightsBest Forex Trading Robots For 2022 TORONTO–(BUSINESS…
News

IMF、サウジの2025年成長率見通しを3%に下方修正

1 Mins read
Manya reports on prominent publicly listed U.S. financial firms, including Wall Street’s biggest banks, card companies, asset managers, and fintechs. She also…

Leave a Reply

Your email address will not be published. Required fields are marked *